SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,764	10,827	11,568	9,300	8,012	6,677
Market Cap Growth	-38.28%	-6.40%	24.39%	16.07%	20.00%	-21.02%
Enterprise Value	7,294	11,388	12,218	9,171	6,991	6,202
Last Close Price	56.60	88.50	93.25	82.01	70.66	58.56
PE Ratio	14.04	20.25	39.25	30.12	143.85	18.54
Forward PE	-	29.34	29.34	39.47	89.36	-
PS Ratio	4.36	7.11	9.61	10.34	9.27	2.48
PB Ratio	1.26	1.98	2.27	2.56	2.41	2.01
P/TBV Ratio	1.26	1.99	2.29	2.60	2.46	2.04
P/FCF Ratio	-	-	-	-	-	8.86
P/OCF Ratio	6.52	12.58	53.62	31.36	28.59	6.87
EV/Sales Ratio	4.70	7.47	10.15	10.19	8.09	2.31
EV/EBITDA Ratio	18.18	26.50	40.23	44.10	51.56	5.24
EV/EBIT Ratio	47.58	57.43	76.22	77.09	94.91	5.90
EV/FCF Ratio	-103.54	-	-	-	-	8.23
Debt / Equity Ratio	0.17	0.18	0.20	0.15	0.00	0.00
Debt / EBITDA Ratio	2.02	2.29	3.41	2.60	0.02	0.00
Debt / FCF Ratio	-	-	-	-	-	0.00
Asset Turnover	0.22	0.22	0.21	0.20	0.20	0.62
Inventory Turnover	1.86	1.94	1.64	1.51	1.94	3.12
Quick Ratio	0.56	0.97	2.35	0.61	1.39	1.33
Current Ratio	1.23	1.64	3.43	1.35	1.87	1.71
Return on Equity (ROE)	9.25%	10.11%	6.75%	8.89%	1.68%	10.60%
Return on Assets (ROA)	1.73%	1.78%	1.72%	1.63%	1.05%	15.19%
Return on Capital (ROIC)	1.93%	1.97%	1.94%	1.98%	1.39%	19.32%
Return on Capital Employed (ROCE)	3.20%	3.20%	2.60%	2.80%	2.10%	30.50%
Earnings Yield	7.13%	4.94%	2.55%	3.32%	0.69%	5.39%
FCF Yield	-1.04%	-0.80%	-7.03%	-9.37%	-6.13%	11.29%
Dividend Yield	2.60%	1.70%	1.34%	0.27%	-	0.63%
Payout Ratio	30.96%	27.94%	8.09%	-	71.36%	128.01%
Buyback Yield / Dilution	-3.64%	-9.44%	-1.87%	-0.08%	0.49%	0.26%
Total Shareholder Return	-1.04%	-7.74%	-0.53%	0.19%	0.49%	0.89%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.